These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 9299613)

  • 1. P32/TAP, a cellular protein that interacts with EBNA-1 of Epstein-Barr virus.
    Wang Y; Finan JE; Middeldorp JM; Hayward SD
    Virology; 1997 Sep; 236(1):18-29. PubMed ID: 9299613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human p32: a coactivator for Epstein-Barr virus nuclear antigen-1-mediated transcriptional activation and possible role in viral latent cycle DNA replication.
    Van Scoy S; Watakabe I; Krainer AR; Hearing J
    Virology; 2000 Sep; 275(1):145-57. PubMed ID: 11017796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-barr virus nuclear antigen-1 binds to nuclear transporter karyopherin alpha1/NPI-1 in addition to karyopherin alpha2/Rch1.
    Ito S; Ikeda M; Kato N; Matsumoto A; Ishikawa Y; Kumakubo S; Yanagi K
    Virology; 2000 Jan; 266(1):110-9. PubMed ID: 10612665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus encoded nuclear protein EBNA-3 binds XAP-2, a protein associated with Hepatitis B virus X antigen.
    Kashuba E; Kashuba V; Pokrovskaja K; Klein G; Szekely L
    Oncogene; 2000 Mar; 19(14):1801-6. PubMed ID: 10777214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The conserved domain CR2 of Epstein-Barr virus nuclear antigen leader protein is responsible not only for nuclear matrix association but also for nuclear localization.
    Yokoyama A; Kawaguchi Y; Kitabayashi I; Ohki M; Hirai K
    Virology; 2001 Jan; 279(2):401-13. PubMed ID: 11162796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
    Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
    J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.
    Fukuma T; Enomoto N; Marumo F; Sato C
    Hepatology; 1998 Oct; 28(4):1147-53. PubMed ID: 9755255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latency pattern of Epstein-Barr virus and methylation status in Epstein-Barr virus-associated hemophagocytic syndrome.
    Yoshioka M; Kikuta H; Ishiguro N; Endo R; Kobayashi K
    J Med Virol; 2003 Jul; 70(3):410-9. PubMed ID: 12767005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An imperfect correlation between DNA replication activity of Epstein-Barr virus nuclear antigen 1 (EBNA1) and binding to the nuclear import receptor, Rch1/importin alpha.
    Kim AL; Maher M; Hayman JB; Ozer J; Zerby D; Yates JL; Lieberman PM
    Virology; 1997 Dec; 239(2):340-51. PubMed ID: 9434725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delineation of a 16 amino acid sequence that forms a core DNA recognition motif in the Epstein-Barr virus EBNA-1 protein.
    Chen MR; Zong J; Hayward SD
    Virology; 1994 Dec; 205(2):486-95. PubMed ID: 7975250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus-encoded nuclear protein EBNA-3 interacts with the epsilon-subunit of the T-complex protein 1 chaperonin complex.
    Kashuba E; Pokrovskaja K; Klein G; Szekely L
    J Hum Virol; 1999; 2(1):33-7. PubMed ID: 10200597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Epstein-Barr virus nuclear antigen-6 protein co-localizes with EBNA-3 and survival of motor neurons protein.
    Krauer KG; Buck M; Belzer DK; Flanagan J; Chojnowski GM; Sculley TB
    Virology; 2004 Jan; 318(1):280-94. PubMed ID: 14972554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical association between the EBV protein EBNA-1 and P32/TAP/hyaluronectin.
    Chen MR; Yang JF; Wu CW; Middeldorp JM; Chen JY
    J Biomed Sci; 1998; 5(3):173-9. PubMed ID: 9678487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter.
    Le Roux A; Kerdiles B; Walls D; Dedieu JF; Perricaudet M
    Virology; 1994 Dec; 205(2):596-602. PubMed ID: 7975264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus-encoded EBNA-5 binds to Epstein-Barr virus-induced Fte1/S3a protein.
    Kashuba E; Yurchenko M; Szirak K; Stahl J; Klein G; Szekely L
    Exp Cell Res; 2005 Feb; 303(1):47-55. PubMed ID: 15572026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr Virus EBNA-2 gene expression enhances lymphotoxin production by B lymphocytes.
    McClain K; Estrov Z; Raju U; Kelley PK; Aggarwal BB
    Methods; 1997 Jan; 11(1):83-7. PubMed ID: 8990093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
    Tong X; Yalamanchili R; Harada S; Kieff E
    J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The p542 gene encodes an autoantigen that cross-reacts with EBNA-1 of the Epstein Barr virus and which may be a heterogeneous nuclear ribonucleoprotein.
    Rhodes GH; Valbracht JR; Nguyen MD; Vaughan JH
    J Autoimmun; 1997 Oct; 10(5):447-54. PubMed ID: 9376072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD; Hsieh JJ; Ruf IK; Rawlins DR; Hayward SD
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulation of Epstein-Barr virus-encoded latent membrane protein by human herpesvirus 6 superinfection of EBV-carrying Burkitt lymphoma cells.
    Cuomo L; Trivedi P; de Grazia U; Calogero A; D'Onofrio M; Yang W; Frati L; Faggioni A; Rymo L; Ragona G
    J Med Virol; 1998 Jul; 55(3):219-26. PubMed ID: 9624610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.